Sub-macular surgery: Is still an option for age-related macular degeneration?

Current Drug Targets

Volumn 12, Issue 2, 2011, Pages 190-198

  Romano, Mario R ^a,b   Valldeperas, Xavier ^c   Vinciguerra, Paolo ^b   Wong, David ^d  

^a UNIVERSITY OF MOLISE   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Age related macular degeneration; Choroidal transplant; Retinal pigment epithelium; Submacular surgery

Indexed keywords

AUTOFLUORESCENCE IMAGING; CATARACT; CHORIODAL NEOVASCULARIZATION; CHOROID; CHOROID DISEASE; CHOROID TRANSLOCATION; EYE SURGERY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LASER COAGULATION; MEDLINE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PERIPHERAL RETINECTOMY; PIGMENT EPITHELIUM; POSTERIOR RETINOTOMY; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA TRANSLOCATION; RETINAL PIGMENT EPITHELIUM GRAFT; REVIEW; SUBMACULAR SURGERY; SURGICAL APPROACH; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; THERAPY EFFECT; VISUAL ACUITY; VISUAL IMPAIRMENT; BLINDNESS; EXUDATIVE MACULAR DEGENERATION; RETINA; RETINA MACULA LUTEA; SUBRETINAL NEOVASCULARIZATION;

BLINDNESS; CHOROIDAL NEOVASCULARIZATION; HUMANS; MACULA LUTEA; POSTOPERATIVE COMPLICATIONS; RETINA; WET MACULAR DEGENERATION;

EID: 79955644519     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945011794182700     Document Type: Review

References (60)

1. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health 2006; 6: 58.
2. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of agerelated macular degeneration in the United States. Arch Ophthalmol 2004; 122: 564-72.
3. Klein R, Klein BE, Tomany SC, et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 2002; 109: 1767-79.
4. Complications of age-related macular degeneration prevention trial study group. The complications of age-related macular degeneration prevention trial (CAPT): rationale, design and methodology. Clin Trials 2004; 1: 91-107.
5. Solomon SD, Jefferys JL, Hawkins BS, Bressler NM. Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to agerelated macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group. Arch Ophthalmol 2007; 125: 1323-30.
6. Kaplan H. Submacular surgery for choroidal neovascularisation. Br J Ophthalmol 1996; 80: 101.
7. Valentino TL, Kaplan HJ, Del Priore LV, et al. Retinal pigment epithelial repopulation in monkeys after submacular surgery. Arch Ophthalmol 1995; 113: 932-8.
8. Hudson HL, Frambach DA, Lopez PF. Relation of the functional and structural fundus changes after submacular surgery for neovascular age-related macular degeneration. Br J Ophthalmol 1995; 79: 417-23.
9. Bressler NM. Submacular surgery. New information, more questions. Arch Ophthalmol 1997; 115: 1071-2.
10. Fan H, Lam JP, Lai WW, Lam DS. Submacular surgery: a potential alternative treatment for subfoveal choroidal neovascularization in age-related macular degeneration. Acta Ophthalmol Scand 2005; 83: 622.
11. Miskala PH, Bass EB, Bressler NM, et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings: SST report no. 12. Ophthalmology 2004; 111: 1981-92.
12. Hawkins BS, Bressler NM, Miskala PH, et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. Ophthalmology 2004; 111: 1967-80.
13. Hawkins BS, Miskala PH, Bass EB, et al. Surgical removal vs. observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST report no. 10. Arch Ophthalmol 2004; 122: 1616-28.
14. Childs AL, Bressler NM, Bass EB, et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: quality-of-life findings: SST report no. 14. Ophthalmology 2004; 111: 2007-14.
15. Bressler NM, Bressler SB, Childs AL, et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology 2004; 111: 1993-2006.
16. Bressler NM, Hawkins BS, Sternberg P Jr, McDonald HR. Are the submacular surgery trials still relevant in an era of photodynamic therapy? Ophthalmology 2001; 108: 435-6.
17. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419-31.
18. Mitchell P, Korobelnik JF, Lanzetta P, et al. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol. 2010; 94: 2-13.
19. Colquitt JL, Jones J, Tan SC, et al. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess 2008; 12: iii-iv, ix-201.
20. Chang TS, Bressler NM, Fine JT, et al. Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 2007; 125: 1460-9.
21. Lantry LE. Ranibizumab, a mAb against VEGF-A for the potential treatment of age-related macular degeneration and other ocular complications. Curr Opin Mol Ther 2007; 9: 592-602.
22. Jeganathan VS, Verma N. Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration. Curr Opin Ophthalmol 2009; 20: 223-5.
23. Toth, CA, Pasquale AC 3rd, Graichen DF. Clinicopathologic correlation of spontaneous retinal pigment epithelial tears with choroidal neovascular membranes in age-related macular degeneration. Ophthalmology 1995; 102: 272-7.
24. Gibran SK, Sachdev A, Stappler T, et al. Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin). Br J Ophthalmol 2007; 91: 602-4.
25. Zhang T, Hu Y, Li Y, et al. Photoreceptors repair by autologous transplantation of retinal pigment epithelium and partial-thickness choroid graft in rabbits. Invest Ophthalmol Vis Sci 2009; 50: 2982-8.
26. Smith TC, Lee L. Age related macular degeneration-new developments in treatment. Aust Fam Physician 2007; 36: 359-61.
27. de Juan E Jr, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 1988; 105: 25-9.
28. Blinder KJ, Peyman GA, Paris CL, Gremillion CM Jr. Submacular scar excision in age-related macular degeneration. Int Ophthalmol 1991; 15: 215-22.
29. Thomas MA, Kaplan HJ. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol 1991; 111: 1-7.
30. Neugebauer A, Fricke J, Aisenbrey S, Russmann W. Cyclotropia in macula translocation. Possible eye muscle surgery solutions. Ophthalmologe 2002; 99: 10-4.
31. Hawkins BS, Bressler NM, Bressler SB, et al. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9. Arch Ophthalmol 2004; 122: 1597-611.
32. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 1993; 111: 1200-9.
33. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 1996; 16: 183-9.
34. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 1991; 109: 1242-57.
35. Dong LM, Childs AL, Mangione CM, et al. Health-and visionrelated quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. Am J Ophthalmol 2004; 138: 91-108.
36. Bressler NM, Bressler SB, Hawkins BS, et al. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1. Am J Ophthalmol 2000; 130: 387-407.
37. No author listed. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: II. Quality of life outcomes submacular surgery trials pilot study report number 2. Am J Ophthalmol 2000; 130: 408-18.
38. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol 1994; 232: 707-16.
39. Vander JF, Federman JL, Greven C, Slusher MM, Gabel VP. Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration. Ophthalmology 1991; 98: 23-7.
40. Joussen AM, Heussen FM, Joeres S, et al. Autologous translocation of the choroid and retinal pigment epithelium in agerelated macular degeneration. Am J Ophthalmol 2006; 142: 17-30.
41. Joussen AM, Joeres S, Fawzy N, et al. Autologous translocation of the choroid and retinal pigment epithelium in patients with geographic atrophy. Ophthalmology 2007; 114: 551-60.
42. Maaijwee K, Heimann H, Missotten T, et al. Retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: long-term results. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1681-9.
43. Gibran SK, Romano MR, Wong D. Perfluorocarbon liquid assisted large retinal epithelium patching in sub-macular hemorrhage secondary to age related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2009; 247: 187-91.
44. Wade EC, Flynn HW Jr, Olsen KR, et al. Subretinal hemorrhage management by pars plana vitrectomy and internal drainage. Arch Ophthalmol 1990; 108: 973-8.
45. Machemer R. Macular translocation. Am J Ophthalmol 1998; 125: 698-700.
46. Aisenbrey S, Lafaut BA, Szurman P, et al. Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol 2002; 120: 451-9.
47. Aisenbrey S, Bartz-Schmidt KU, Walter P, et al. Long-term follow-up of macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol 2007; 125: 1367-72.
48. Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol 2002; 134: 560-5.
49. Mruthyunjaya P, Stinnett SS, Toth CA. Impact of fluorescein angiographic characteristics of macular lesions on outcomes after macular translocation 360 degree surgery in eyes with age-related macular degeneration. Retina 2005; 25: 597-607.
50. Fujikado T, Asonuma S, Ohji M, et al. Reading ability after macular translocation surgery with 360-degree retinotomy. Am J Ophthalmol 2002; 134: 849-56.
51. Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology 2005; 112: 144-51.
52. Wong D, Stanga P, Briggs M, et al. Case selection in macular relocation surgery for age related macular degeneration. Br J Ophthalmol 2004; 88: 186-90.
53. Luke M, Ziemssen F, Volker M, et al. Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMTPDT). Graefes Arch Clin Exp Ophthalmol 2009; 247: 745-54.
54. Gamulescu MA, Framme C, Sachs H. RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularised PED secondary to AMD. Graefes Arch Clin Exp Ophthalmol 2007; 245:1037-40.
55. The Macular Photocoagulation Study. Age-related macular degeneration. Am J Ophthalmol 1984; 98: 376-7.
56. Ruiz-Moreno JM, Montero JA, Zarbin MA. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative agerelated macular degeneration: 2-year outcome. Retina 2007; 27: 458-61.
57. Joussen AM, Wong D, Walter P, et al. MARAN study group. Surgical management of subfoveal choroidal neovascular membranes in age-related macular degeneration by macular relocation: experiences of an early-stopped randomised clinical trial (MARAN Study). Eye 2010; 24: 284-9
58. Meyer CH, Scholl HP, Eter N, et al. Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study. Acta Ophthalmol 2008; 86: 490-4.
59. Wong D, Durnian JM. Surgical treatment of age-related macular degeneration: will there be a role in the future? Clin Experiment Ophthalmol 2007; 35: 167-73.
60. Lux A, Llacer H, Heussen FM, Joussen AM. Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br J Ophthalmol 2007; 91: 1318-22.